Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Orchid Island Capital, Inc is a reit-mortgage business based in the US. Orchid Island Capital shares (ORC) are listed on the NYSE and all prices are listed in US Dollars.
|52-week range||USD$1.3216 - USD$5.82|
|50-day moving average||USD$5.4288|
|200-day moving average||USD$5.2786|
|Wall St. target price||USD$5.75|
|Dividend yield||USD$0.835 (14.52%)|
|Earnings per share (TTM)||USD$0.065|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Orchid Island Capital stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Orchid Island Capital's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Orchid Island Capital's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 88x. In other words, Orchid Island Capital shares trade at around 88x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Revenue TTM||USD$14.7 million|
|Operating margin TTM||28.9%|
|Gross profit TTM||USD$32.3 million|
|Return on assets TTM||0.11%|
|Return on equity TTM||1.11%|
|Market capitalisation||USD$487.7 million|
TTM: trailing 12 months
There are currently 5.3 million Orchid Island Capital shares held short by investors – that's known as Orchid Island Capital's "short interest". This figure is 12.4% down from 6.0 million last month.
There are a few different ways that this level of interest in shorting Orchid Island Capital shares can be evaluated.
Orchid Island Capital's "short interest ratio" (SIR) is the quantity of Orchid Island Capital shares currently shorted divided by the average quantity of Orchid Island Capital shares traded daily (recently around 2.0 million). Orchid Island Capital's SIR currently stands at 2.66. In other words for every 100,000 Orchid Island Capital shares traded daily on the market, roughly 2660 shares are currently held short.
However Orchid Island Capital's short interest can also be evaluated against the total number of Orchid Island Capital shares, or, against the total number of tradable Orchid Island Capital shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Orchid Island Capital's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Orchid Island Capital shares in existence, roughly 60 shares are currently held short) or 0.0625% of the tradable shares (for every 100,000 tradable Orchid Island Capital shares, roughly 63 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Orchid Island Capital.
Find out more about how you can short Orchid Island Capital stock.
Dividend payout ratio: 22.9% of net profits
Recently Orchid Island Capital has paid out, on average, around 22.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 13.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Orchid Island Capital shareholders could enjoy a 13.71% return on their shares, in the form of dividend payments. In Orchid Island Capital's case, that would currently equate to about $0.835 per share.
While Orchid Island Capital's payout ratio might seem low, this can signify that Orchid Island Capital is investing more in its future growth.
Orchid Island Capital's most recent dividend payout was on 29 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
Over the last 12 months, Orchid Island Capital's shares have ranged in value from as little as $1.3216 up to $5.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Orchid Island Capital's is 1.3554. This would suggest that Orchid Island Capital's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Orchid Island Capital, Inc., a specialty finance company, invests in residential mortgage-backed securities (RMBS) in the United States. The company's RMBS are backed primarily by single-family residential mortgage loans, referred as Agency RMBS. Its portfolio includes traditional pass-through Agency RMBS, such as mortgage pass through certificates and collateralized mortgage obligations; and structured Agency RMBS, including interest only securities, inverse interest only securities, and principal only securities. The company qualifies as a real estate investment trust for federal income tax purposes. The company was founded in 2010 and is headquartered in Vero Beach, Florida.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.